Angiodynamics (ANGO) Restructuring Costs (2012 - 2026)

Angiodynamics' Restructuring Costs history runs 15 years deep, the most recent figure standing at $4.7 million for Q2 2026.

• Quarterly Restructuring Costs rose 117.31% year-over-year to $4.7 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $30.4 million (up 94.47% YoY) and the FY2026 annual result came in at $17.6 million, up 12.66% from the prior year.
• Restructuring Costs was $4.7 million for Q2 2026 at Angiodynamics, down from $19.3 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $35.4 million in Q1 2024 and bottomed at $2.0 million in Q2 2022.
• A 5-year average of $6.6 million and a median of $3.6 million in 2023 frame the typical range for Restructuring Costs.
• Annual changes were most pronounced in 2024 — Restructuring Costs surged 949.78% — and 2025, when it plunged 90.71%.
• Angiodynamics' Restructuring Costs stood at $3.1 million in 2022, then jumped by 102.29% to $6.2 million in 2023, then dropped by 5.17% to $5.9 million in 2024, then plunged by 38.05% to $3.6 million in 2025, then grew by 28.83% to $4.7 million in 2026.
• Business Quant data shows ANGO's Restructuring Costs at $4.7 million in Q2 2026, $19.3 million in Q1 2026, and $3.6 million in Q4 2025.